In this free webinar, attendees will gain insights into novel methodologies for precise and efficient DNA and RNA synthesis. Attendees will learn about nucleic acids beyond genetic encoding, including ...

Dr. Shuyang Zhang (Department of Rare Diseases, Peking Union Medical College Hospital) and Dr. He Huang (Shanghai Institute of Materia Medica, Chinese Academy of Sciences).

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

In addition, the team proposed that non-histone lactylation levels accumulate progressively from 1 week to 6 months (6 m), whereas histone lactylation levels decrease rapidly from 1 to 6 weeks ...

Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

A new review published in Genes & Diseases on long non-coding RNAs (lncRNAs) highlights their critical role in the ...

Good afternoon ladies and gentlemen, and welcome to Alector fourth quarter and full year 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I ...

Dr. Shuyang Zhang (Department of Rare Diseases, Peking Union Medical College Hospital) and Dr. He Huang (Shanghai Institute ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...